ALX ONCOLOGY HOLDINGS INC Quarterly Operating Income (Loss) in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Alx Oncology Holdings Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q3 2024.
  • Alx Oncology Holdings Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$32.6M, a 38.9% increase year-over-year.
  • Alx Oncology Holdings Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$160M, a 3.5% decline year-over-year.
  • Alx Oncology Holdings Inc annual Operating Income (Loss) for 2023 was -$170M, a 33.6% decline from 2022.
  • Alx Oncology Holdings Inc annual Operating Income (Loss) for 2022 was -$127M, a 52.5% decline from 2021.
  • Alx Oncology Holdings Inc annual Operating Income (Loss) for 2021 was -$83.6M, a 91.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$160M -$32.6M +$20.7M +38.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$181M -$41.5M -$4.75M -12.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$176M -$37.8M -$5.56M -17.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$170M -$48M -$15.8M -49.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$154M -$53.3M -$16.6M -45.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$138M -$36.8M -$2.99M -8.84% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$135M -$32.2M -$7.46M -30.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$127M -$32.2M -$3.75M -13.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$124M -$36.7M -$12.1M -49.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$112M -$33.8M -$17.5M -107% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$94.1M -$24.7M -$10.5M -74.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$83.6M -$28.5M -$10.6M -59.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 -$72.9M -$24.6M -$14.8M -151% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$58.1M -$16.3M -$5.51M -51.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$52.6M -$14.2M -$8.97M -171% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$43.7M -$17.8M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-09
Q3 2020 -$9.81M -$6.78M -223% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$10.8M -$6.6M -158% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$5.24M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2019 -$3.03M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$4.19M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.